Acherx LLC
Seattle, WA
- UEI
- YD7XSWBYR3W1
- CAGE
- 717U0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- SAM.gov registration date
- Physical address
- 2319 1st Ave Apartment 305, Seattle, WA 98121, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Explore slow-release formulation of a peptide therapeutic for migraine | National Institute of Neurological Disorders and Stroke (NIH) | $1,493,686 |
Quick answers
Is Acherx LLC registered in SAM.gov?
Yes. Acherx LLC's SAM.gov registration is active through March 10, 2027.
What is Acherx LLC's most recent federal award?
Acherx LLC's most recent federal grant award is Explore slow-release formulation of a peptide therapeutic for migraine (R43NS120440), from National Institute of Neurological Disorders and Stroke (NIH), on September 1, 2021.
On GovTribe
See Acherx LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors